Cyclophosphamide W/or W/Out Rituximab and Peripheral Stem Cell Transplantation in Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00028665 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
DRUG: carmustine
DRUG: cisplatin
DRUG: cyclophosphamide
DRUG: etoposide
PROCEDURE: bone marrow ablation with stem cell support
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: radiation therapy

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]